title: Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints.
abstract: The effects of the endogenous cannabinoid anandamide were studied on peripheral, polymodal nociceptors recorded from normal and chronically inflamed (Freund's adjuvant) knee joint afferents in rats anaesthetized with pentobarbitone. Anandamide (860 nmol) caused a rapid, short lasting excitation of a sub-population of capsaicin-sensitive nociceptive afferents in normal knee joints (7.2+/-2.3 impulses s(-1); n=15 units from five animals). In arthritic joints there were 9.7+/-3.0 impulses s(-1) (n=11 from six animals), which was not significantly different from normal joints. The excitation was dose dependent (8.6 - 2900 nmol) and mediated by activation of the vanilloid receptor (VR(1)) as it was abolished by the VR1 antagonist capsazepine (1 mg kg(-1)). Our results show that anandamide, at high doses, can activate nociceptive afferents innervating the rat knee joints, in contrast with its widely described analgesic actions.
authors.affiliation: Sensory Pharmacology Unit, Department of Neuroscience, University of Edinburgh, Edinburgh, EH8 9JZ. S.Gauldie@ed.ac.uk
authors.forename: S D
authors.initials: SD
authors.lastname: Gauldie
authors.forename: D S
authors.initials: DS
authors.lastname: McQueen
authors.forename: R
authors.initials: R
authors.lastname: Pertwee
authors.forename: I P
authors.initials: IP
authors.lastname: Chessell
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000627:therapeutic use*; D001169:Arthritis, Experimental / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002211:Capsaicin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004195:Disease Models, Animal; D004347:Drug Interactions; D063388:Endocannabinoids; D007719:Knee Joint; D008297:Male; D009619:Nociceptors / Q000187:drug effects / Q000378:metabolism*; D053284:Polyunsaturated Alkamides; D051381:Rats; D017208:Rats, Wistar; D011955:Receptors, Drug / Q000037:antagonists & inhibitors / Q000378:metabolism; D050916:TRPV Cation Channels; D016896:Treatment Outcome
chemical_list: D001095:Arachidonic Acids; D002121:Calcium Channel Blockers; D063388:Endocannabinoids; D053284:Polyunsaturated Alkamides; D011955:Receptors, Drug; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; C071423:capsazepine; D002211:Capsaicin; C078814:anandamide